Vorinostat Completed Phase 1 Trials for Malignant Solid Tumours / Non Small Cell Lung Carcinoma (NSCLC) / Renal Cell Adenocarcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00635791Phase I Study of Vorinostat and Sorafenib in Advanced Cancer